Sanofi Shares Fall After Multiple Sclerosis Drug Gets Hit by Double Setback
(feeds.content.dowjones.io)
1.
2.
Sanofi Multiple Sclerosis Drug Hit by Double Setback
(feeds.content.dowjones.io)